Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Immunotherapy

  • Open Access
    Radiotherapy and Immunotherapy: The Power of the Teamwork for the Treatment of NSCLC
    MARIA BASSANELLI, SARA RAMELLA, MASSIMO ZEULI and ANNA CERIBELLI
    Anticancer Research May 2022, 42 (5) 2241-2247; DOI: https://doi.org/10.21873/anticanres.15704
  • Open Access
    Chemotherapy Can Synergize With Adoptive Immunotherapy to Inhibit Medulloblastoma Growth
    JOSEPH L. LASKY, KATHRYN L. BRADFORD, YUNTAO WANG, YOUNGJU PAK and EDUARD H. PANOSYAN
    Anticancer Research April 2022, 42 (4) 1697-1706; DOI: https://doi.org/10.21873/anticanres.15646
  • You have access
    Efficacy of a Flat Low Dose of Nivolumab in Advanced Cancer: A Retrospective Case Series
    SOFIE JORIS, CHRISTEL FONTAINE, LORE DECOSTER, JACQUES VANDERAUWERA, KRIS THIELEMANS, WIM WAELPUT and JACQUES DE-GRÈVE
    Anticancer Research March 2022, 42 (3) 1433-1437; DOI: https://doi.org/10.21873/anticanres.15613
  • You have access
    Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active?
    CHIARA CICCARESE, ROBERTO IACOVELLI, SEBASTIANO BUTI, FRANCESCA PRIMI, SERENA ASTORE, FRANCESCO MASSARI, MIRIAM GRAZIA FERRARA, GIUSEPPE PALERMO, NAZARIO FOSCHI, VALERIO IACOVELLI, ERNESTO ROSSI, GIOVANNI SCHINZARI, PIERLUIGI BOVE, PIERFRANCESCO BASSI, EMILIO BRIA and GIAMPAOLO TORTORA
    Anticancer Research March 2022, 42 (3) 1487-1493; DOI: https://doi.org/10.21873/anticanres.15620
  • You have access
    Characteristics of Human Peripheral Blood γδ T Cells Expanded With Zoledronate
    MINSONG KIM, HYORI KIM, MINA HAN, HYUN JU HWANG, HYERY KIM, HO JOON IM, NAYOUNG KIM and KYUNG-NAM KOH
    Anticancer Research December 2021, 41 (12) 6031-6038; DOI: https://doi.org/10.21873/anticanres.15422
  • You have access
    A DNA Topoisomerase II Inhibitor Results in Ex Vivo Differentiation of THP-1 Cells and Activation of Dendritic Cells
    YOUNG JIN CHO, HEEJAE LEE, JIHYEONG KIM, GYUNGYUB GONG, HEE JIN LEE and IN AH PARK
    Anticancer Research December 2021, 41 (12) 6087-6094; DOI: https://doi.org/10.21873/anticanres.15428
  • You have access
    The Role of Immune Checkpoint Inhibitors in Leptomeningeal Disease: A Systematic Review
    PAOLO PALMISCIANO, ALI S. HAIDER, CHIBUEZE D. NWAGWU, WASEEM WAHOOD, KENNY YU, CHIBAWANYE I. ENE, BARBARA J. O’BRIEN, SALAH G. AOUN, AARON A. COHEN-GADOL and TAREK Y. EL AHMADIEH
    Anticancer Research November 2021, 41 (11) 5333-5342; DOI: https://doi.org/10.21873/anticanres.15346
  • You have access
    SLAMF7 and TREM1 Mediate Immunogenic Cell Death in Colorectal Cancer Cells: Focus on Microsatellite Stability
    SEON AE ROH, YI HONG KWON, JONG LYUL LEE, SEON-KYU KIM and JIN CHEON KIM
    Anticancer Research November 2021, 41 (11) 5431-5444; DOI: https://doi.org/10.21873/anticanres.15355
  • You have access
    Stereotactic and Hypofractionated Radiotherapy Associated With Immune Checkpoint Inhibitor Drugs: Analysis of Local Control, Toxicity, and Outcome in a Single Research Centre Case Study
    DIMITRI ANZELLINI, VITALIANA DE SANCTIS, MAURIZIO VALERIANI, CHIARA REVERBERI, LUCA MARINELLI, MARIA MASSARO, GIANLUCA VULLO, GIUSEPPE FACONDO, RICCARDO CARLO SIGILLO, EMANUELE TOSI and MATTIA FALCHETTO OSTI
    Anticancer Research October 2021, 41 (10) 5107-5116; DOI: https://doi.org/10.21873/anticanres.15327
  • You have access
    Intensity-modulated Radiotherapy in Patients With Aggressive Extranodal Non-Hodgkin Lymphoma of the Head and Neck
    JENS EISMANN, KHALED ELSAYAD, DANIEL ROLF, IQBAL SARIF, EVA WARDELMANN, HENDRIK BERSSENBRÜGGE, GEORG LENZ and HANS THEODOR EICH
    Anticancer Research October 2021, 41 (10) 5131-5135; DOI: https://doi.org/10.21873/anticanres.15330

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 10
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire